FA
GILD icon

FMA Advisory’s Gilead Sciences GILD Stock Holding History

FMA Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$29K Buy
+250
New +$27.3K 0.02% 220

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FMA Advisory's GILD Position: Q2 2015 in Review

FMA Advisory opened a new position in Gilead Sciences (GILD) in Q2 2015: 250 shares worth $29K. The stake represents 0.02% of the portfolio and ranks #220 among its holdings.

1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • FMA Advisory held 250 shares of Gilead Sciences worth $29K as of Q2 2015.
  • Gilead Sciences was a new FMA Advisory position in Q2 2015.
  • Gilead Sciences made up 0.02% of FMA Advisory's portfolio in Q2 2015, its #220 holding.
  • 1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.